STOCK TITAN

Phibro Animal Health (NASDAQ: PAHC) COO sells 635 shares for tax withholding

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Phibro Animal Health Chief Operating Officer Larry Lee Miller reported a disposition of 635 shares of Class A Common Stock on August 4, 2026. The shares were sold at $36.599 per share in a broker-assisted cashless exercise to satisfy tax withholding obligations related to restricted stock unit vesting. Following the transaction, he directly held 34,549 shares.

Positive

  • None.

Negative

  • None.
Insider Miller Larry Lee
Role Chief Operating Officer
Type Security Shares Price Value
Other Class A Common Stock F1 635 $36.599 $23K
Holdings After Transaction: Class A Common Stock — 34,549 shares (Direct)
Footnotes (1)
  1. F1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Shares disposed 635 shares of Class A Common Stock Shares sold on August 4, 2026 to satisfy tax withholding
Sale price per share $36.599 per share Price for the 635-share broker-assisted cashless sale
Shares held after transaction 34,549 shares Direct ownership of Class A Common Stock following the sale
broker assisted cashless exercise program financial
"Represents shares sold in a broker assisted cashless exercise program"
tax withholding obligations financial
"to satisfy tax withholding obligations upon the receipt of Class A"
restricted stock units financial
"in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did PAHC Chief Operating Officer Larry Lee Miller report?

Larry Lee Miller reported disposing of 635 shares of Phibro Animal Health Class A Common Stock on August 4, 2026, through a broker-assisted cashless exercise aimed at covering tax withholding from restricted stock unit vesting.

How many PAHC shares did the COO sell and at what price?

He sold 635 shares of Phibro Animal Health Class A Common Stock at $36.599 per share. The transaction was executed as part of a broker-assisted cashless exercise specifically to satisfy associated tax withholding obligations.

Why were Larry Lee Miller’s PAHC shares sold in this Form 4 filing?

The 635 shares were sold in a broker-assisted cashless exercise to satisfy tax withholding obligations triggered when Class A Common Stock was received upon vesting and settlement of restricted stock units, rather than as a discretionary open-market sale.

How many PAHC shares does the COO hold after this reported transaction?

After the reported tax-related sale, Larry Lee Miller directly holds 34,549 shares of Phibro Animal Health Class A Common Stock. This figure reflects his position immediately following the 635-share disposition reported in the Form 4 data.

Was the PAHC COO’s reported share sale linked to restricted stock units (RSUs)?

Yes. The footnote explains the sale represents shares sold to cover taxes upon receiving Class A Common Stock in connection with the vesting and settlement of restricted stock units, executed via a broker-assisted cashless exercise program.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Miller Larry Lee

(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NEW JERSEY 07059

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/04/2026J635(1)D$36.59934,549D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
/s/ Judith Weinstein, as Attorney-in-Fact for Larry Lee Miller08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)